Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Clinical trial NCT00565539 · COMPLETED

Trial details

NCT number: NCT00565539
Sponsor: ZymoGenetics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2007-12-01
Primary completion: 2009-10-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.